Table 5.

Chemotherapy in node-positive disease and endocrine treatment in estrogen-receptor-positive disease, by age: registry and country

		Women with node-positive tumours											Women with estrogen-receptor-positive tumours
					15–49 years				50–99 years				No.	Endocrine treatment		15–49 years				50–99 years
EUROPE	Registry	No.	Chemo- therapy		Total		Chemo- therapy		Total		Chemo- therapy					Total		Endocrine treatment		Total		Endocrine treatment
			No.	%	No.	%	No.	%	No.	%	No.	%		No.	%	No.	%	No.	%	No.	%	No.	%
Denmark	National	204	43	21	35	17	19	54	169	83	24	14	340	115	34	52	15	4	8	288	0	111	39
Estonia	National	300	236	79	81	27	76	94	219	73	160	73	110	94	85	34	31	24	71	76	69	70	92
Finland	National	189	71	38	52	28	41	79	137	72	30	22	376	125	33	89	24	21	24	287	76	104	36
France	Bas-Rhin	63	48	76	17	27	17	100	46	73	31	67	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
	Côte d’Or	194	110	57	67	35	58	87	127	65	52	41	396	220	56	106	27	33	31	290	73	187	64
	Doubs	94	59	63	25	27	21	84	69	73	38	55	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
	Isère	78	50	64	20	26	19	95	58	74	31	53	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
	Tarn	86	52	60	23	27	21	91	63	73	31	49	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Iceland	National	178	97	54	59	33	53	90	119	67	44	37	303	162	53	77	25	32	42	226	75	130	58
Italy	Genova1	193	139	72	46	24	42	91	147	76	97	66
	Modena	169	129	76	45	27	40	89	124	73	89	72	320	221	69	75	23	59	79	245	77	162	66
	Palermo	252	198	79	77	31	75	97	175	69	123	70	209	148	71	70	33	53	76	139	67	95	68
	Varese	455	250	55	131	29	90	69	324	71	160	49	685	246	36	157	23	42	27	528	77	204	39
Netherlands	Eindhoven	477	181	38	144	30	133	92	333	70	48	14	552	189	34	149	27	18	12	403	73	171	42
	NE Netherlands	823	323	39	236	29	220	93	587	71	103	18	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Poland	Cracow	336	184	55	84	25	74	88	252	75	110	44	104	66	63	22	21	13	59	82	79	53	65
	Warsaw	290	157	54	96	33	80	83	194	67	77	40	89	61	69	26	29	10	38	63	71	51	81
Slovakia	National	288	219	76	99	34	91	92	189	66	128	68	93	49	53	34	37	12	35	59	63	37	63
Slovenia	National	402	282	70	108	27	106	98	294	73	176	60	385	227	59	88	23	24	27	297	77	203	68
Spain	Basque Country	228	190	83	87	38	84	97	141	62	106	75	260	213	82	76	29	49	64	184	71	164	89
	Castellon	327	240	73	85	26	82	96	242	74	158	65	355	290	82	86	24	70	81	269	76	220	82
	Granada	237	178	75	72	30	71	99	165	70	107	65	157	127	81	45	29	29	64	112	71	98	88
	Navarra	169	138	82	67	40	67	100	102	60	71	70	317	252	79	86	27	72	84	231	73	180	78
Sweden	National	159	45	28	34	21	27	79	125	79	18	14	248	123	50	41	17	7	17	207	83	116	56
European registries		6,191	3,619	58	1,790	29	1,607	90	4,401	71	2,012	46	5,299	2,928	55	1,313	25	572	44	3,986	75	2,356	59
US	State
	California	154	107	69	55	36	46	84	99	64	61	62	287	157	55	68	24	31	46	219	76	126	58
	Colorado	155	113	73	51	33	48	94	104	67	65	63	290	192	66	73	25	47	64	217	75	145	67
	Illinois	133	87	65	43	32	39	91	90	68	48	53	233	129	55	45	19	23	51	188	81	106	56
	Louisiana	155	102	66	38	25	32	84	117	75	70	60	260	116	45	40	15	18	45	220	85	98	45
	New York	155	106	68	47	30	42	89	108	70	64	59	228	147	64	42	18	20	48	186	82	127	68
	Rhode Island	128	84	66	34	27	32	94	94	73	52	55	301	245	81	68	23	52	76	233	77	193	83
	South Carolina	121	89	74	35	29	31	89	86	71	58	67	186	121	65	39	21	26	67	147	79	95	65
US registries		1,001	688	69	303	30	270	89	698	70	418	60	1,785	1,107	62	375	21	217	58	1,410	79	890	63

n/a - not available

¹Registries were excluded if data on treatment were unavailable for more than 20% of women: Genova (hormonal treatment), Firenze and Ragusa (both treatments)